Wilms' tumor suppressor gene (WT1) is expressed in primary breast tumors despite tumor-specific promoter methylation.
about
Active specific immunotherapy targeting the Wilms' tumor protein 1 (WT1) for patients with hematological malignancies and solid tumors: lessons from early clinical trialsDenys-Drash syndrome associated WT1 glutamine 369 mutants have altered sequence-preferences and altered responses to epigenetic modificationsThe pleural mesothelium in development and diseasePleural mesothelial cells in pleural and lung diseasesGenome-wide mapping of Polycomb target genes unravels their roles in cell fate transitionsIn silico regulatory analysis for exploring human disease progression.The plasticizer butyl benzyl phthalate induces genomic changes in rat mammary gland after neonatal/prepubertal exposure.WT1-associated protein is a novel prognostic factor in pancreatic ductal adenocarcinoma.The Wilms' tumor suppressor WT1 induces estrogen-independent growth and anti-estrogen insensitivity in ER-positive breast cancer MCF7 cells.Diagnostic utility of WT-1 cytoplasmic stain in variety of vascular lesionsPrognostic significance of WT1 expression in soft tissue sarcoma.Oxygen-Dependent Gene Expression in Development and Cancer: Lessons Learned from the Wilms' Tumor Gene, WT1Prognostic significance of specific anti-WT1 IgG antibody level in plasma in patients with ovarian carcinomaHypoxia-sensitive epigenetic regulation of an antisense-oriented lncRNA controls WT1 expression in myeloid leukemia cellsWilms' tumor gene 1 (WT1) silencing inhibits proliferation of malignant peripheral nerve sheath tumor sNF96.2 cell line.Aberrant DNA methylation of cancer-related genes in giant breast fibroadenoma: a case report.Wilms' tumor gene 1 regulates p63 and promotes cell proliferation in squamous cell carcinoma of the head and neckWT1/EGR1-mediated control of STIM1 expression and function in cancer cellsHypermethylated Epidermal growth factor receptor (EGFR) promoter is associated with gastric cancerAssociation between WT1 polymorphisms and susceptibility to breast cancer: results from a case-control study in a southwestern Chinese populationWilms' tumor 1 silencing decreases the viability and chemoresistance of glioblastoma cells in vitro: a potential role for IGF-1R de-repressionMethylation target array for rapid analysis of CpG island hypermethylation in multiple tissue genomesThe Wilms' tumor suppressor WT1 regulates expression of members of the epidermal growth factor receptor (EGFR) and estrogen receptor in acquired tamoxifen resistance.Investigation of the role of SDHB inactivation in sporadic phaeochromocytoma and neuroblastoma.Induction of Wilms' tumor protein (WT1)-specific antitumor immunity using a truncated WT1-expressing adenovirus vaccineActivity of a Py-Im polyamide targeted to the estrogen response element.Hippo Signaling Mediators Yap and Taz Are Required in the Epicardium for Coronary Vasculature DevelopmentThe Wilms' tumor suppressor WT1 inhibits malignant progression of neoplastigenic mammary epithelial cells.Association of WT1 IgG antibody against WT1 peptide with prolonged survival in glioblastoma multiforme patients vaccinated with WT1 peptide.Epigenetic silencing contributes to the loss of BRMS1 expression in breast cancer.Transcriptional repression of tumor suppressor CDC73, encoding an RNA polymerase II interactor, by Wilms tumor 1 protein (WT1) promotes cell proliferation: implication for cancer therapeutics.Hypermethylation of the alternative AWT1 promoter in hematological malignancies is a highly specific marker for acute myeloid leukemias despite high expression levels.WT1 shRNA delivery using transferrin-conjugated PEG liposomes in an in vivo model of melanoma.Epigenetic therapy in urologic cancers: an update on clinical trials.WT1 expression in breast cancer disrupts the epithelial/mesenchymal balance of tumour cells and correlates with the metabolic response to docetaxel.WT1 protein expression in astrocytic tumors and its relationship with cellular proliferation index.Wilms' tumor gene 1 silencing inhibits proliferation of human osteosarcoma MG-63 cell line by cell cycle arrest and apoptosis activation.WT1 regulates angiogenesis in Ewing SarcomaWilms' tumour 1 can suppress hTERT gene expression and telomerase activity in clear cell renal cell carcinoma via multiple pathways.WT1 protein directly regulates expression of vascular endothelial growth factor and is a mediator of tumor response to hypoxia.
P2860
Q27026836-6893E312-75B3-45D7-9504-81D079DD1BD9Q27728005-D6BA5332-0FF5-4FA0-B130-DF8C05B6329DQ28391520-8607F624-C43C-4A5F-821A-88483A7D7654Q28396403-0774A28D-19E0-4C6A-867B-68889FCCCE84Q29614512-FC194C3A-6536-430A-A60F-D32C4CD432B8Q30482686-FC2140A8-9BE6-454F-9032-7B12F8B8E341Q33308926-9F96AFA1-7A06-4675-9661-8D213A1DBF30Q33598160-81E15AC6-F6D2-4B1D-B4C2-4D2AAB990E91Q33723383-246974F4-377A-43F8-9105-BB62B3E46DEDQ33802698-0CEAF6BF-8ABF-4F3F-9F19-BCF356E01411Q33965010-8C246C36-D745-4387-BD6B-F6D16C54798CQ34617481-74C3D531-73CC-4C09-A7E2-A6D20625B110Q35000449-235B5F8B-C63B-4438-8F3B-287D1B21D315Q35203507-CA847F5F-BCA4-4015-B386-422B58202701Q35489149-6BB927DF-0EF1-43EF-B8CC-3057D37525D2Q35509530-614FEC4D-5BDD-4D83-9341-C7890FD3AB20Q35575285-C798CDE0-337A-456E-8BFD-21E55D83655FQ35575649-E8F92EF4-1C08-4CCD-A74D-B1295D55702CQ35591083-DC2FB9DC-E9FF-46EA-9D45-6BAC8DCFA471Q35666497-ACF615DE-E1E5-4C0C-82B0-DD88896D44D9Q35751162-B5B1445F-3B09-442B-AC20-CB852FF2AB23Q35791618-790A1025-A07F-4B87-BB37-9E5A65AA4C5FQ36049015-57FF5828-87FF-4E39-A0FE-DA86E12C7582Q36696226-6891911B-CDB3-4B99-B091-00C05E582F71Q36781571-068EA45E-478D-4C55-AB46-13490AC82D40Q36836841-01B40E87-44FF-4835-ACC0-FBEB604025B6Q36913611-D950DC06-22C8-4C78-AD37-5D78F8A164ADQ37121492-C7042DFA-0C8A-49D9-B1C1-02F5215F1F9DQ37384745-FE7C16FC-B66F-48BF-A6E2-8A6035B15C8EQ37391196-8750483D-CAE8-4AC1-8D97-CEF0892224D4Q37459352-E7807BAB-F35B-4A43-B3F3-0A67C54E81D2Q37510844-F75FB12C-162D-4CF9-A225-089DFBAF066AQ37582083-5E5966C7-D9DD-4FFF-945C-53287E98562CQ37707110-794E3F18-226F-4048-8977-CB24725B303AQ37721627-89F8314C-23D3-47D9-B472-049342EBD6FAQ38395134-A5D4E7DF-D2F4-478F-AB12-357772159F45Q38720362-A6C7B777-E74B-4271-A715-5222C6916CF8Q38997010-9D7B2424-56B6-4DB7-8714-38E5F73C9625Q39655836-771E91FD-860F-45B4-ABA3-47534F9ED6D9Q39937224-BE89EE4B-3946-4414-9566-E316BBC0DC75
P2860
Wilms' tumor suppressor gene (WT1) is expressed in primary breast tumors despite tumor-specific promoter methylation.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
2001年论文
@zh
2001年论文
@zh-cn
name
Wilms' tumor suppressor gene ( ...... specific promoter methylation.
@en
type
label
Wilms' tumor suppressor gene ( ...... specific promoter methylation.
@en
prefLabel
Wilms' tumor suppressor gene ( ...... specific promoter methylation.
@en
P2093
P1433
P1476
Wilms' tumor suppressor gene ( ...... -specific promoter methylation
@en
P2093
Buluwela L
Niranjan B
Weitzman SA
P304
P407
P577
2001-02-01T00:00:00Z